SelectX Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of small molecule antimicrobials and other therapeutics for unmet medical needs through the application of its innovative Genetic Chemistry platform. The company’s most advanced lead is an aminoglycoside antibiotic that addresses the rapidly emerging resistant gram-negative hospital infection market. Genetic Chemistry is defining a new paradigm for drug discovery, offering significant technical and economic advantages, as well as expediency in product development.